ClinicalTrials.Veeva

Menu

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

U

Università degli Studi di Ferrara

Status

Completed

Conditions

Biochemical Marker
Blood Transfusion

Study type

Observational

Funder types

Other

Identifiers

NCT02917811
20042016

Details and patient eligibility

About

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Enrollment

250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unselected ICU patients

Exclusion criteria

  • Length of stay in ICU <48 hours
  • Hematological disease
  • Age <18 years

Trial design

250 participants in 1 patient group

ICU patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems